Microwave zaps prostate tumors with 3D precision
NCT ID NCT04582656
First seen Jun 26, 2026 · Last updated Jun 27, 2026 · Updated 1 time
Summary
This study tested a new way to treat intermediate-risk prostate cancer using a 3D map to guide microwaves directly to the main tumor. 76 men across Europe received the treatment, and researchers checked if the cancer was gone after 12 months. The goal is to destroy the cancer while avoiding damage to healthy tissue, potentially reducing side effects like incontinence and impotence.
What this could mean
Our plain-language read of the trial. This is informational only — not medical advice or a prediction.
Active substance
microwave ablation (device)
What this could lead to
If successful, this could offer a less invasive treatment option for intermediate-risk prostate cancer, potentially reducing side effects compared to surgery or radiation.
What could go wrong
This is a small, single-arm study with only 76 participants and no comparison group. The long-term effectiveness and safety beyond 12 months are unknown.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for PROSTATE CANCER are added.
By submitting, you agree to our Terms of use
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Locations
-
American Hospital of Paris
Neuilly-sur-Seine, 92200, France
-
Centre Hospitalier Universitaire de Bordeaux
Bordeaux, 33000, France
-
Hôpital Cochin (Assistance Publique - Hôpitaux de Paris)
Paris, 75014, France
-
Institut Jules Bordet
Brussels, 1000, Belgium
-
Urologie Nantes Clinique & Institut d'Urologie - Site Atlantis
Saint-Herblain, 44800, France